Obeticholic Acid (CAS 459789-99-2)

Application and positioning

Obeticholic acid is a farnesoid X receptor (FXR) agonist supplied as the free acid. It is used in oral tablets for primary biliary cholangitis, typically as add-on therapy in patients with inadequate response to ursodeoxycholic acid. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.

Quality and documentation

• Batch-specific Certificate of Analysis issued by the manufacturing site
• SDS/MSDS and specification sheet available on request
• Residual solvents and elemental impurities statements discussed per project
• For pharmaceutical manufacturing and R&D use only — not for direct administration

Packaging and handling

• Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
• Small quantities in sealed aluminium foil bags
• Palletised for air and sea freight; store dry, ventilated and protected from light

Related products

• Simeprevir Sodium (CAS 1241946-89-3)
• Sofosbuvir (CAS 1190307-88-0)
• Tenofovir Alafenamide Fumarate (CAS 1392275-56-7)
• Velpatasvir (CAS 1377049-84-7)

Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.